Clinical Roundup Economic loss from U.S. cigarette smoking topped almost $900B in 2020, study shows September 30, 2022Vol.48 No.35
Clinical Roundup Over 16,000 cancer deaths due to complications from COVID-19 in 2020 in US, new ACS study says September 30, 2022Vol.48 No.35
Drugs & Targets Merck’s Keytruda receives four approvals in Japan, including in high-risk early-stage TNBC September 30, 2022Vol.48 No.35
Conversation with The Cancer Letter Jefferson’s Andrew Chapman tells us what it’s like to be the first geriatric oncology expert to run a cancer center September 23, 2022Vol.48 No.34By Paul Goldberg
NCI Lowy’s AACR keynote: “Unacceptable” disparities in cancer outcomes mar 21st century progress September 23, 2022Vol.48 No.34By Matthew Bin Han Ong
AACR Cancer Progress Report urges improving health equity, prevention September 23, 2022Vol.48 No.34By Jacquelyn Cobb
In Brief Scott M. Welford named Tumor Biology Research Program co-leader at Sylvester September 23, 2022Vol.48 No.34
In Brief UCSD receives $16M NIH FIRST Award to recruit 12 diverse, early-career researchers September 23, 2022Vol.48 No.34
